These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8493922)

  • 1. Human cytosolic aldehyde dehydrogenase in androgen insensitivity syndrome.
    Pereira FA; Rosenmann E; Nylen EG; Wrogemann K
    Adv Exp Med Biol; 1993; 328():45-50. PubMed ID: 8493922
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological role of human cytosolic aldehyde dehydrogenase 1: hormonal response, retinal oxidation and implication in testicular feminization.
    Yoshida A; Hsu LC; Yanagawa Y
    Adv Exp Med Biol; 1993; 328():37-44. PubMed ID: 8493914
    [No Abstract]   [Full Text] [Related]  

  • 3. Residual androgen binding in testicular feminization (TFM).
    Fox TO; Blank D; Politch JA
    J Steroid Biochem; 1983 Jul; 19(1B):577-81. PubMed ID: 6887886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen insensitivity in forty-nine patients: classification based on clinical and androgen receptor phenotypes.
    Hughes IA; Evans BA
    Horm Res; 1987; 28(1):25-9. PubMed ID: 3447937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays.
    Avila DM; Wilson CM; Nandi N; Griffin JE; McPhaul MJ
    J Clin Endocrinol Metab; 2002 Jan; 87(1):182-8. PubMed ID: 11788645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete androgen insensitivity associated with a thermolabile androgen receptor.
    Hasegawa T; Imasaki K; Haji M; Hasegawa Y; Aso T; Koto S; Tsuchiya Y; Kawamura T; Shinohara O; Nawata H
    Endocr J; 1994 Feb; 41(1):31-5. PubMed ID: 7951549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative androgen receptors distinguished in wild-type and testicular-feminized (Tfm) mice.
    Wieland SJ; Fox TO
    Cell; 1979 Aug; 17(4):781-7. PubMed ID: 487429
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytosolic androgen receptor in skeletal muscle from normal and testicular feminization mutant (Tfm) rats.
    Max SR
    Biochem Biophys Res Commun; 1981 Aug; 101(3):792-9. PubMed ID: 6975622
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
    Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor in human skin cytosol.
    Mowszowicz I; Riahi M; Wright F; Bouchard P; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1981 Feb; 52(2):338-44. PubMed ID: 6970202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subcellular defects in the androgen insensitivity syndrome.
    Swoboda W; Herkner K
    Acta Endocrinol Suppl (Copenh); 1986; 279():396-402. PubMed ID: 3465175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.
    Brown TR; Migeon CJ
    J Clin Endocrinol Metab; 1986 Mar; 62(3):542-50. PubMed ID: 3944238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 56 kDa androgen binding protein is an aldehyde dehydrogenase.
    Pereira F; Rosenmann E; Nylen E; Kaufman M; Pinsky L; Wrogemann K
    Biochem Biophys Res Commun; 1991 Mar; 175(3):831-8. PubMed ID: 1709013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males.
    Elmlinger MW; Mayer I; Schnabel D; Schuett BS; Diesing D; Romalo G; Wollmann HA; Weidemann W; Spindler KD; Ranke MB; Schweikert HU
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4741-6. PubMed ID: 11600534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital androgen insensitivity due to a qualitatively abnormal androgen receptor.
    Pinsky L; Kaufman M; Summitt RL
    Am J Med Genet; 1981; 10(1):91-9. PubMed ID: 7294064
    [No Abstract]   [Full Text] [Related]  

  • 16. Androgen receptor knockout and knock-in mouse models.
    Kerkhofs S; Denayer S; Haelens A; Claessens F
    J Mol Endocrinol; 2009 Jan; 42(1):11-7. PubMed ID: 18923000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen insensitivity syndrome: clinical features and molecular defects.
    Galani A; Kitsiou-Tzeli S; Sofokleous C; Kanavakis E; Kalpini-Mavrou A
    Hormones (Athens); 2008; 7(3):217-29. PubMed ID: 18694860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene.
    Trifiro M; Gottlieb B; Pinsky L; Kaufman M; Prior L; Belsham DD; Wrogemann K; Brown CJ; Willard HF; Trapman J
    Mol Cell Endocrinol; 1991 Jan; 75(1):37-47. PubMed ID: 2050265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Androgen insensitivity syndrome. Clinical features and molecular genetics].
    Sólyom J; Scheiber D; Fekete G
    Orv Hetil; 2001 Aug; 142(31):1659-65. PubMed ID: 11556259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.